Pasireotide in Prevention of GI Toxicity

Summary

The purpose of this study is to evaluate if the drug, Pasireotide, is safe and effective in reducing the gastrointestinal side effects of the drugs received to prepare for allogeneic stem cell transplant. The study will also evaluate if Pasireotide is effective in reducing acute and chronic Graft-versus-Host-Disease (GvHD) after transplant.

Timeline

Start

2015-01-21

Primary completion

2019-02-28

Completion

2019-10-15

Drugs

Indications